Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future

Area of Science:

• Pediatric Infectious Diseases
• Antimicrobial Resistance
• Public Health

Background:

• Antibiotic resistance is a critical global health issue, causing significant mortality, particularly in newborns.
• Pediatric antibiotic resistance is exacerbated by factors unique to children, including antibiotic overuse and a lack of age-specific clinical data.
• The developing physiology of children presents pharmacokinetic challenges, and certain antibiotics are contraindicated, further complicating treatment.

Purpose of the Study:

• To highlight the multifaceted challenges of antibiotic resistance in the pediatric population.
• To underscore the urgent need for pediatric-specific research and data to combat rising antimicrobial resistance.
• To emphasize the potential return to a pre-antibiotic era if current trends continue.

Main Methods:

• This study is a review and synthesis of existing data on pediatric antibiotic resistance.
• Analysis of World Health Organization (WHO) data on multidrug-resistant infections.
• Identification of emerging resistant pathogens and challenges in pediatric pharmacotherapy.

Main Results:

• Multidrug-resistant bacteria cause approximately 700,000 deaths annually across all ages, with 200,000 in newborns.
• Pediatric-specific challenges include antibiotic misuse, age-dependent pharmacokinetic variations, and drug contraindications.
• Emerging threats include MRSA, VRSA, ESBL-producing and carbapenem-resistant Enterobacteriaceae, and colistin resistance.

Conclusions:

• Addressing antibiotic resistance in children requires tailored strategies due to unique physiological and treatment challenges.
• Increased pediatric-specific research and judicious antibiotic use are crucial to mitigate this public health crisis.
• Failure to act could lead to a post-antibiotic era, endangering infant lives from common infections.